BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 10760106)

  • 1. Effect of peritonitis on peritoneal transport characteristics: glucose solution versus polyglucose solution.
    Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
    Kidney Int; 2000 Apr; 57(4):1704-12. PubMed ID: 10760106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal fluid and solute transport with different polyglucose formulations.
    Wang T; Heimbürger O; Cheng HH; Bergström J; Lindholm B
    Perit Dial Int; 1998; 18(2):193-203. PubMed ID: 9576369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronan prevents the decreased net ultrafiltration caused by increased peritoneal dialysate fill volume.
    Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
    Kidney Int; 1998 Feb; 53(2):496-502. PubMed ID: 9461112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal fluid kinetics: comparison between polyglucose solution and albumin solution.
    Wang T; Cheng HH; Heimbürger O; Bergström J; Lindholm B
    Adv Perit Dial; 1999; 15():21-7. PubMed ID: 10682066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of increased dialysate fill volume on peritoneal fluid and solute transport.
    Wang T; Heimbürger O; Cheng H; Waniewski J; Bergström J; Lindholm B
    Kidney Int; 1997 Oct; 52(4):1068-76. PubMed ID: 9328947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High peritoneal residual volume decreases the efficiency of peritoneal dialysis.
    Wang T; Cheng HH; Heimbürger O; Bergström J; Lindholm B
    Kidney Int; 1999 May; 55(5):2040-8. PubMed ID: 10231469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronan decreases peritoneal fluid absorption: effect of molecular weight and concentration of hyaluronan.
    Wang T; Cheng HH; Heimbürger O; Chen C; Waniewski J; Bergström J; Lindholm B
    Kidney Int; 1999 Feb; 55(2):667-73. PubMed ID: 9987091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal atrial natriuretic peptide increases peritoneal fluid and solute removal.
    Wang T; Cheng HH; Heimbürger O; Chen C; Bergström J; Lindholm B
    Kidney Int; 2001 Aug; 60(2):513-9. PubMed ID: 11473634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraperitoneal addition of hyaluronan improves peritoneal dialysis efficiency.
    Wang T; Cheng HH; Heimbürger O; Chen C; Waniewski J; Bergström J; Lindholm B
    Perit Dial Int; 1999; 19 Suppl 2():S106-11. PubMed ID: 10406503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between peritoneal permeability and ultrafiltration volume with icodextrin-based peritoneal dialysis solution.
    Moriishi M; Kawanishi H; Watanabe H; Tsuchiya S
    Adv Perit Dial; 2004; 20():166-9. PubMed ID: 15384820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluid and solute transport using different sodium concentrations in peritoneal dialysis solutions.
    Cheng HH; Wang T; Heimbürger O; Bergström J; Lindholm B
    Perit Dial Int; 2001; 21(1):65-71. PubMed ID: 11280498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells.
    Douma CE; Hiralall JK; de Waart DR; Struijk DG; Krediet RT
    Kidney Int; 1998 Apr; 53(4):1014-21. PubMed ID: 9551412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphotericin B does not increase peritoneal fluid removal.
    Wang T; Heimbürger O; Cheng HH; Bergström J; Lindholm B
    Adv Perit Dial; 1998; 14():3-10. PubMed ID: 10649681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of icodextrin in peritoneal dialysis patients.
    Moberly JB; Mujais S; Gehr T; Hamburger R; Sprague S; Kucharski A; Reynolds R; Ogrinc F; Martis L; Wolfson M
    Kidney Int Suppl; 2002 Oct; (81):S23-33. PubMed ID: 12230479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronan preserves peritoneal membrane transport properties.
    Guo QY; Peng WX; Cheng HH; Ye RG; Lindholm B; Wang T
    Perit Dial Int; 2001; 21(2):136-42. PubMed ID: 11330556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Icodextrin metabolism and alpha-amylase activity in nonuremic rats undergoing chronic peritoneal dialysis.
    García-López E; Pawlaczyk K; Anderstam B; Qureshi AR; Kuzlan-Pawlaczyk M; Heimbürger O; Werynski A; Lindholm B
    Perit Dial Int; 2007; 27(4):415-23. PubMed ID: 17602150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Icodextrin degradation products in spent dialysate of CAPD patients and the rat, and its relation with dialysate osmolality.
    de Waart DR; Zweers MM; Struijk DG; Krediet RT
    Perit Dial Int; 2001; 21(3):269-74. PubMed ID: 11475342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic analysis of peritoneal fluid and solute transport with combination of glucose and icodextrin as osmotic agents.
    Galach M; Werynski A; Waniewski J; Freida P; Lindholm B
    Perit Dial Int; 2009; 29(1):72-80. PubMed ID: 19164256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasodilatation by intraperitoneal addition of nitroprusside is not a model for high peritoneal transport.
    Wang T; Cheng HH; Heimbürger O; Bergström J; Lindholm B
    Adv Perit Dial; 1999; 15():53-9. PubMed ID: 10682072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal transport characteristics with glycerol-based dialysate in peritoneal dialysis.
    Smit W; de Waart DR; Struijk DG; Krediet RT
    Perit Dial Int; 2000; 20(5):557-65. PubMed ID: 11117247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.